Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.34B | $2.13B | $2.40B | $2.27B | $2.30B | $2.07B | $2.26B | $2.10B |
| Cost of revenue | $1.37B | $1.32B | $1.47B | $1.39B | $1.41B | $1.30B | $1.40B | $1.32B |
| Gross profit | $963.00M | $803.00M | $932.00M | $883.00M | $892.00M | $768.00M | $857.00M | $784.00M |
| Gross margin | 41.2% | 37.8% | 38.9% | 38.9% | 38.8% | 37.1% | 38.0% | 37.3% |
| Research and development | $59.00M | $56.00M | $60.00M | $52.00M | $58.00M | $56.00M | $58.00M | $55.00M |
| Selling, general and administrative | $503.00M | $472.00M | $486.00M | $474.00M | $503.00M | $460.00M | $507.00M | $445.00M |
| Operating expenses | $573.00M | $559.00M | $579.00M | $549.00M | $587.00M | $537.00M | $590.00M | $504.00M |
| Operating income | $390.00M | $244.00M | $353.00M | $334.00M | $305.00M | $231.00M | $267.00M | $280.00M |
| Operating margin | 16.7% | 11.5% | 14.7% | 14.7% | 13.3% | 11.2% | 11.8% | 13.3% |
| EBITDA | $541.00M | $415.00M | $529.00M | $499.00M | $476.00M | $397.00M | $434.00M | $425.00M |
| Interest expense | −$7.00M | −$4.00M | −$6.00M | −$6.00M | −$9.00M | −$8.00M | −$9.00M | −$10.00M |
| Income before taxes | $364.00M | $244.00M | $368.00M | $297.00M | $299.00M | $217.00M | $375.00M | $269.00M |
| Income taxes | $103.00M | $55.00M | $35.00M | $71.00M | $75.00M | $50.00M | $49.00M | $52.00M |
| Net income | $261.00M | $189.00M | $333.00M | $226.00M | $224.00M | $167.00M | $326.00M | $217.00M |
| Net margin | 11.2% | 8.9% | 13.9% | 10.0% | 9.7% | 8.1% | 14.5% | 10.3% |
| EPS, basic | $1.11 | $0.79 | $1.38 | $0.93 | $0.93 | $0.69 | $1.34 | $0.89 |
| EPS, diluted | $1.11 | $0.79 | $1.37 | $0.93 | $0.93 | $0.69 | $1.34 | $0.89 |
| Diluted shares | 236.57M | 243.36M | 244.25M | 244.09M | 243.86M | 243.78M | 243.78M | 243.75M |
Figures describe Xylem shares, not any token. As of Jul 28, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.